Primerica Inc. Common Stock (PRI)
StalwartFairStock Score: 75/100 — HIGH CONVICTION
Key Financials
| Current Price | $274.43 |
| Market Cap | $8.4B |
| P/E Ratio | 11.03 |
| ROE | 32.97% |
| Dividend Yield | 1.65% |
| Sector | Financial Services |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
As a Buffett/Graham style investor, I ask whether Primerica is a durable business at a sensible price. It sells term life and investment products to middle-income households, largely through a distributed sales force, a business that can generate recurring premiums and fees if persistency and underwriting stay sound. The filed numbers show fiscal Q2 2026 (quarter ended 2026-06-30) revenue of $865.1 million, net income of $202.3 million, and diluted EPS of $6.45, versus fiscal Q2 2025 (quarter ended 2025-06-30) revenue of $793.3 million, net income of $178.3 million, and diluted EPS of $5.40. Fiscal 2025 (year ended 2025-12-31) revenue was $3.3 billion, net income $751.2 million, and diluted EPS $22.91, up sharply from fiscal 2024 (year ended 2024-12-31) net income of $470.5 million and diluted EPS of $13.71, though fiscal 2023 (year ended 2023-12-31) net income was higher at $576.6 million. FairStock's calculations put the shares at 11.15 times earnings and 3.40 times book at the 2026-10-13 close, with a 32.97% ROE, 0.72 debt-to-equity, and a 0.83 PEG. That combination looks reasonably attractive if earnings are sustainable. However, the FairStock Piotroski F-score is only 5/9, ROCE is 4.66%, and I cannot see CET1, net interest margin, or a combined ratio, key bank/insurer safety measures not in the data. Primerica looks like a steady grower with high returns on equity and moderate leverage, but not a deep bargain on book value, and insurance underwriting risk remains the wildcard.
In plain English: Primerica sells term life insurance and savings products to middle-income families in the U.S. and Canada. The business has been profitable and growing, with high returns on shareholders' money and a small dividend. Based on its recent profits, the stock price looks fair to somewhat cheap, though the company does not disclose some key insurance safety details here.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash
Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)
Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer